Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...

Avanza Fonder AB reduced its stake in Amgen by 15.2% in Q1, selling nearly 9,000 shares but still holding $15.3 million. The biotech behemoth remains the 28th largest holding for Avanza, proving it's ...

In the latest close session, Amgen (AMGN) was up +1.88% at $297.29. The stock outpaced the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.24%, and the technology-dominated ...

Wesbanco Bank just pumped up its Amgen stock by 23.2%, scooping up over 64,000 shares worth nearly $20 million. This ...

Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 9:20 PM ETCompany ParticipantsJames E.

Amgen Inc. closed 15.40% below its 52-week high of $346.85, which the company reached on July 25th.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin ...